Story perspectives
Genomic Discoveries Enhance Multiple Myeloma Outcomes and Detection
8/22/2025
1 of 1
Story summary
- Recent studies identify structural variants in the genomic landscape of multiple myeloma that affect clinical outcomes.
- Monoclonal gammopathy of undetermined significance (MGUS) is recognized as a precursor to multiple myeloma.
- Multi-parametric flow cytometry improves detection rates of plasma cell disorders.
- Genomic and immune signatures serve as predictors of outcomes in newly diagnosed multiple myeloma patients.
